AST SpaceMobile Shares Fall as Rival SpaceMD Adds Ex-Merck, NASA Veterans
ASTS•AST SpaceMobile shares dipped 0.22% on July 8 as investors noted its selection among three ‘forgotten’ space economy stocks projected to deliver significant gains over the next decade. Meanwhile, SpaceMD, a Redwire venture, appointed former Merck investigator Paul Reichert and ex-NASA technology director Niki Werkheiser to lead orbital drug development initiatives.
1. AST SpaceMobile Stock Movement
AST SpaceMobile shares declined 0.22% on July 8, reflecting sector volatility after announcements across the space industry and renewed investor focus on long-term growth candidates within the space economy.
2. SpaceMD Advisory Appointments
SpaceMD, a microgravity pharmaceuticals venture backed by Redwire Corporation, named Paul Reichert, former Merck Principal Investigator, and Niki Werkheiser, ex-Director of Technology Maturation at NASA, to its strategic advisory board to accelerate in-orbit drug research and manufacturing.
3. Inclusion in Space Economy 'Hidden Gems' List
AST SpaceMobile was featured among three overlooked space economy companies highlighted for potential ‘colossal gains’ over the next ten years, underscoring market interest in companies enabling satellite-based broadband and communications infrastructure.
4. Implications and Outlook
The entry of industry veterans into SpaceMD could intensify competition in space-based pharmaceutical research, while AST SpaceMobile’s positioning as a long-term growth stock may support its valuation as investors weigh sector developments.
